Request for Information From Non-Federal Stakeholders on Progress and Accomplishments (2010-2015) Towards the Goals of the National Vaccine Plan, 61214-61215 [2015-25818]

Download as PDF 61214 Federal Register / Vol. 80, No. 196 / Friday, October 9, 2015 / Notices Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov. OMB Comment OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Email: OIRA_ SUBMISSION@OMB.EOP.GOV. Attn: Desk Officer for the Administration for Children and Families. Robert Sargis, Reports Clearance Officer. ‘‘All Atomic Weapons Employees who worked at the Hooker Electrochemical Corporation in Niagara Falls, New York, during the operational period from July 1, 1944, through December 31, 1948, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.’’ This designation will become effective on October 22, 2015, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2015–25757 Filed 10–8–15; 8:45 am] BILLING CODE 4163–19–P [FR Doc. 2015–25737 Filed 10–8–15; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Designation of a Class of Employees for Addition to the Special Exposure Cohort Request for Information From NonFederal Stakeholders on Progress and Accomplishments (2010–2015) Towards the Goals of the National Vaccine Plan National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice of a decision to designate a class of employees from the Hooker Electrochemical Corporation in Niagara Falls, New York, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 1090 Tusculum Avenue, MS C– 46, Cincinnati, OH 45226–1938, Telephone 1–877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. SUPPLEMENTARY INFORMATION: SUMMARY: tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 7384l(14)(C). On September 22, 2015, as provided for under 42 U.S.C. 7384l(14)(C),the Secretary of HHS designated the following class of employees as an addition to the SEC: VerDate Sep<11>2014 17:44 Oct 08, 2015 Jkt 238001 The development of a National Vaccine Plan was mandated by Congress as a mechanism for the Director of the National Vaccine Program (the Assistant Secretary for Health) to communicate priorities for achieving the Program’s responsibilities of ensuring adequate supply of and access to vaccines and ensuring the effective and optimal use of vaccines. The National Vaccine Plan, released in 2010, provides a comprehensive 10-year national strategy for enhancing all aspects of the National Vaccine Program including: Research and development, supply, financing, distribution, safety, informed decision making by consumers and health care providers, vaccine preventable disease surveillance, vaccine effectiveness and use monitoring, and global cooperation (https://www.hhs.gov/nvpo/vacc_plan/ index.html). In accordance with the 2010 National Vaccine Plan (NVP), the National Vaccine Program Office (NVPO) is PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 conducting a mid-course review of the Plan following five years of its implementation. This review is intended to ensure that the priorities and activities outlined in the NVP are appropriately aligned towards the goals described therein given significant changes in the immunization landscape that have occurred since the NVP was released in 2010. The NVP is intended to be a national plan that includes contributions from both federal and non-federal stakeholders. In order to collect information from non-federal stakeholders in a uniform and systematic way, the NVPO is issuing a Request for Information (RFI) through a structured survey accessed on the NVPO Web site at https://www.hhs.gov/nvpo/ vacc_plan/#mid-coursereview. The RFI will solicit specific information regarding the priorities, goals, and objectives within the NVP, significant accomplishments since 2010, remaining gaps, and stakeholder perspectives on priorities of the vaccine and immunization community for the remaining years of the NVP (2016– 2020). Finally, stakeholders will also be provided the opportunity to briefly inform NVPO of the top contributions from their organization. DATES: Survey responses on the National Vaccine Plan must be completed and submitted online by midnight, 12:00 a.m. EDT on November 9, 2015. ADDRESSES: All those interested in participating in the survey to provide information on the National Vaccine Plan should do so by clicking on the survey link provided on the NVPO Web site at https://www.hhs.gov/nvpo/vacc_ plan/#mid-course-review. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, Office of the Assistant Secretary for Health, Department of Health and Human Services; telephone (202) 690–5566; email: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The National Vaccine Program was established in compliance with Title XXI of the Public Health Service Act (Pub. L. 99–660) (§ 2101) (42 U.S. Code 300aa–et seq (PDF—78 KB)) to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. Development of a National Vaccine Plan has been mandated to the National Vaccine Program Office as a mechanism for the Director of the National Vaccine Program (the Assistant Secretary for E:\FR\FM\09OCN1.SGM 09OCN1 tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 196 / Friday, October 9, 2015 / Notices Health) to communicate priorities for both federal and non-federal stakeholders regarding vaccine research and the development, testing, licensing, production, procurement, distribution, and effective use of vaccines in order to carry out the Program’s responsibilities. The immunization landscape has changed notably since the introduction of the NVP in 2010 and its subsequent implementation plan. New vaccines were developed. New vaccination related technologies were advanced and the passage of the Patient Protection and Affordable Care Act presented a unique opportunity for vaccination with its emphasis on preventive health. Increased access to immunizations has also changed the dynamic of immunization delivery. While increased demand for immunizations moves us toward the goal of better vaccine coverage and the reduction of vaccine preventable diseases, the costs of administering vaccines have risen over time and created additional stresses on the immunization infrastructure. These include costs for vaccine procurement, costs associated with proper vaccine storage and handling, insurance against loss, opportunity costs, and personnel costs such as managing inventory, vaccine counseling, administration, and entering data into medical records and immunization registries. Moreover, public health departments and local jurisdictions must navigate additional demands such as improving health information technology use, adherence to Meaningful Use requirements, outbreak detection and response, and public health preparedness and response efforts with limited (and oftentimes diminishing) resources. The use of social media and online communications to distribute vaccine information and misinformation has also expanded greatly in the past few years- bringing public trust in vaccines and the immunization system to the forefront of national conversations. Outbreaks of vaccine-preventable diseases such as measles and pertussis have highlighted the need for accessible and ongoing educational materials about the risks of vaccine preventable diseases and the risks and benefits of vaccinations. Finally, the momentum built from the 2010–2020 Decade of Vaccines Initiative, emerging global health crises such as the Ebola outbreaks in Western Africa, and imported cases of vaccinepreventable diseases such as measles have highlighted that U.S. efforts to support our national vaccine goals must also serve as building blocks for strengthening efforts towards the VerDate Sep<11>2014 17:44 Oct 08, 2015 Jkt 238001 detection and prevention of infectious diseases world-wide. In accordance with the 2010 National Vaccine Plan (NVP), the National Vaccine Program Office (NVPO) is conducting a mid-course review of the NVP to ensure that the goals and objectives are appropriately aligned towards the goals described therein given significant changes in the immunization landscape that have occurred since the NVP was released in 2010. This analysis could include, but may not be limited to, evaluating the priority areas described in the Plan, identifying significant accomplishments and continued areas of opportunity towards the goals and objectives outlined in the 2010 NVP, and developing updated 2015–2020 priorities and indicators to optimize implementation efforts to better align with the current immunization landscape. This input will be used to inform Departmental priorities and activities going forward. II. Request for Information In order to capture non-federal stakeholder input in a targeted and systematic way, NVPO is conducting a Request for Information using an on-line survey tool to compile information regarding the priorities, goals, and objectives within the NVP, significant accomplishments since 2010, remaining gaps, and stakeholder perspectives on priorities of the vaccine and immunization community for the remaining years of the NVP (2016– 2020). Finally, stakeholders will also be provided the opportunity to briefly inform NVPO of the top contributions from their organization. A link to the survey and instructions for completing the survey can be accessed via the NVPO Web site at https://www.hhs.gov/ nvpo/vacc_plan/#midcourse-review. All information collected will be aggregated and analyzed to help inform a high level summary of the overall progress towards the goals in the NVP. All responses to this Request for Information must be submitted by completing the online survey tool. Information collection sponsored by the NVPO required for the purposes of informing the National Vaccine Program and the National Vaccine Plan is not subject to Chapter 35 of title 44, United States Code [the Paperwork Reduction Act] as indicated in 42 U.S.C. 300aa–1 note (section 321 of Pub. L. 99–660). All survey submissions will become part of the public record and subject to public disclosure. While the survey tool does not solicit identifying information, submissions that contain this PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 61215 information will not be edited to remove any identifying. III. Potential Responders HHS invites input from a broad range of stakeholders including individuals and organizations that have interests in vaccines and immunization efforts and goals outlined in the 2010 National Vaccine Plan. Examples of potential responders include, but are not limited to, the following: —General public; —advocacy groups, non-profit organizations, and public interest organizations; —academics, professional societies, and healthcare organizations; —public health officials and immunization program managers; —physician and non-physician providers that administer immunization services, including pharmacists and community vaccinators —representatives from the private sector. Dated: September 25, 2015. Michelle Y. Blakely, Senior Advisor and Acting Chief of Operations and Management, National Vaccine Program Office. [FR Doc. 2015–25818 Filed 10–8–15; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Request for Public Comment: 60-Day Proposed Information Collection: Indian Health Service (IHS) Sharing What Works—Best Practice, Promising Practice, and Local Effort (BPPPLE) Form (OMB NO. 0917–0034) Indian Health Service, HHS. Notice and request for comments. Request for extension of approval. AGENCY: ACTION: In compliance with the Paperwork Reduction Act of 1995, Public Law (Pub. L.) 104–13 [44 United States Code (U.S.C.) § 3506(c)(2)(A)], the Indian Health Service (IHS) invites the general public to take this opportunity to comment on the information collection titled, ‘‘Indian Health Service (IHS) Sharing What Works—Best Practice, Promising Practice, and Local Effort (BPPPLE) Form,’’ Office of Management and Budget (OMB) Control Number 0917–0034. This previously approved information collection project was last published in SUMMARY: E:\FR\FM\09OCN1.SGM 09OCN1

Agencies

[Federal Register Volume 80, Number 196 (Friday, October 9, 2015)]
[Notices]
[Pages 61214-61215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25818]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Information From Non-Federal Stakeholders on Progress 
and Accomplishments (2010-2015) Towards the Goals of the National 
Vaccine Plan

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY:  The development of a National Vaccine Plan was mandated by 
Congress as a mechanism for the Director of the National Vaccine 
Program (the Assistant Secretary for Health) to communicate priorities 
for achieving the Program's responsibilities of ensuring adequate 
supply of and access to vaccines and ensuring the effective and optimal 
use of vaccines. The National Vaccine Plan, released in 2010, provides 
a comprehensive 10-year national strategy for enhancing all aspects of 
the National Vaccine Program including: Research and development, 
supply, financing, distribution, safety, informed decision making by 
consumers and health care providers, vaccine preventable disease 
surveillance, vaccine effectiveness and use monitoring, and global 
cooperation (https://www.hhs.gov/nvpo/vacc_plan/).
    In accordance with the 2010 National Vaccine Plan (NVP), the 
National Vaccine Program Office (NVPO) is conducting a mid-course 
review of the Plan following five years of its implementation. This 
review is intended to ensure that the priorities and activities 
outlined in the NVP are appropriately aligned towards the goals 
described therein given significant changes in the immunization 
landscape that have occurred since the NVP was released in 2010.
    The NVP is intended to be a national plan that includes 
contributions from both federal and non-federal stakeholders. In order 
to collect information from non-federal stakeholders in a uniform and 
systematic way, the NVPO is issuing a Request for Information (RFI) 
through a structured survey accessed on the NVPO Web site at https://www.hhs.gov/nvpo/vacc_plan/#mid-course-review. The RFI will 
solicit specific information regarding the priorities, goals, and 
objectives within the NVP, significant accomplishments since 2010, 
remaining gaps, and stakeholder perspectives on priorities of the 
vaccine and immunization community for the remaining years of the NVP 
(2016-2020). Finally, stakeholders will also be provided the 
opportunity to briefly inform NVPO of the top contributions from their 
organization.

DATES: Survey responses on the National Vaccine Plan must be completed 
and submitted online by midnight, 12:00 a.m. EDT on November 9, 2015.

ADDRESSES: All those interested in participating in the survey to 
provide information on the National Vaccine Plan should do so by 
clicking on the survey link provided on the NVPO Web site at https://www.hhs.gov/nvpo/vacc_plan/#mid-course-review.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services; telephone (202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The National Vaccine Program was established in compliance with 
Title XXI of the Public Health Service Act (Pub. L. 99-660) (Sec.  
2101) (42 U.S. Code 300aa-et seq (PDF--78 KB)) to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. 
Development of a National Vaccine Plan has been mandated to the 
National Vaccine Program Office as a mechanism for the Director of the 
National Vaccine Program (the Assistant Secretary for

[[Page 61215]]

Health) to communicate priorities for both federal and non-federal 
stakeholders regarding vaccine research and the development, testing, 
licensing, production, procurement, distribution, and effective use of 
vaccines in order to carry out the Program's responsibilities.
    The immunization landscape has changed notably since the 
introduction of the NVP in 2010 and its subsequent implementation plan. 
New vaccines were developed. New vaccination related technologies were 
advanced and the passage of the Patient Protection and Affordable Care 
Act presented a unique opportunity for vaccination with its emphasis on 
preventive health.
    Increased access to immunizations has also changed the dynamic of 
immunization delivery. While increased demand for immunizations moves 
us toward the goal of better vaccine coverage and the reduction of 
vaccine preventable diseases, the costs of administering vaccines have 
risen over time and created additional stresses on the immunization 
infrastructure. These include costs for vaccine procurement, costs 
associated with proper vaccine storage and handling, insurance against 
loss, opportunity costs, and personnel costs such as managing 
inventory, vaccine counseling, administration, and entering data into 
medical records and immunization registries. Moreover, public health 
departments and local jurisdictions must navigate additional demands 
such as improving health information technology use, adherence to 
Meaningful Use requirements, outbreak detection and response, and 
public health preparedness and response efforts with limited (and 
oftentimes diminishing) resources. The use of social media and online 
communications to distribute vaccine information and misinformation has 
also expanded greatly in the past few years- bringing public trust in 
vaccines and the immunization system to the forefront of national 
conversations. Outbreaks of vaccine-preventable diseases such as 
measles and pertussis have highlighted the need for accessible and 
ongoing educational materials about the risks of vaccine preventable 
diseases and the risks and benefits of vaccinations.
    Finally, the momentum built from the 2010-2020 Decade of Vaccines 
Initiative, emerging global health crises such as the Ebola outbreaks 
in Western Africa, and imported cases of vaccine-preventable diseases 
such as measles have highlighted that U.S. efforts to support our 
national vaccine goals must also serve as building blocks for 
strengthening efforts towards the detection and prevention of 
infectious diseases world-wide.
    In accordance with the 2010 National Vaccine Plan (NVP), the 
National Vaccine Program Office (NVPO) is conducting a mid-course 
review of the NVP to ensure that the goals and objectives are 
appropriately aligned towards the goals described therein given 
significant changes in the immunization landscape that have occurred 
since the NVP was released in 2010. This analysis could include, but 
may not be limited to, evaluating the priority areas described in the 
Plan, identifying significant accomplishments and continued areas of 
opportunity towards the goals and objectives outlined in the 2010 NVP, 
and developing updated 2015-2020 priorities and indicators to optimize 
implementation efforts to better align with the current immunization 
landscape. This input will be used to inform Departmental priorities 
and activities going forward.

II. Request for Information

    In order to capture non-federal stakeholder input in a targeted and 
systematic way, NVPO is conducting a Request for Information using an 
on-line survey tool to compile information regarding the priorities, 
goals, and objectives within the NVP, significant accomplishments since 
2010, remaining gaps, and stakeholder perspectives on priorities of the 
vaccine and immunization community for the remaining years of the NVP 
(2016-2020). Finally, stakeholders will also be provided the 
opportunity to briefly inform NVPO of the top contributions from their 
organization. A link to the survey and instructions for completing the 
survey can be accessed via the NVPO Web site at https://www.hhs.gov/nvpo/vacc_plan/#mid-course-review. All information collected 
will be aggregated and analyzed to help inform a high level summary of 
the overall progress towards the goals in the NVP.
    All responses to this Request for Information must be submitted by 
completing the online survey tool. Information collection sponsored by 
the NVPO required for the purposes of informing the National Vaccine 
Program and the National Vaccine Plan is not subject to Chapter 35 of 
title 44, United States Code [the Paperwork Reduction Act] as indicated 
in 42 U.S.C. 300aa-1 note (section 321 of Pub. L. 99-660).
    All survey submissions will become part of the public record and 
subject to public disclosure. While the survey tool does not solicit 
identifying information, submissions that contain this information will 
not be edited to remove any identifying.

III. Potential Responders

    HHS invites input from a broad range of stakeholders including 
individuals and organizations that have interests in vaccines and 
immunization efforts and goals outlined in the 2010 National Vaccine 
Plan.
    Examples of potential responders include, but are not limited to, 
the following:

--General public;
--advocacy groups, non-profit organizations, and public interest 
organizations;
--academics, professional societies, and healthcare organizations;
--public health officials and immunization program managers;
--physician and non-physician providers that administer immunization 
services, including pharmacists and community vaccinators
--representatives from the private sector.

    Dated: September 25, 2015.
Michelle Y. Blakely,
Senior Advisor and Acting Chief of Operations and Management, National 
Vaccine Program Office.
[FR Doc. 2015-25818 Filed 10-8-15; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.